Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by donkeyfeatherson Jan 25, 2022 8:40pm
244 Views
Post# 34360635

RE:RE:RE:RE:RE:RE:Exciting update!!

RE:RE:RE:RE:RE:RE:Exciting update!!

SBD,
Our board chair announced that he was going to take a more hands on approach now.  I'm imagining he feels some obligation for all the DSU's he granted himself.  He's also a long time friend of the IR guy who helped bring DL of Leed Jones into our world of 1,000,000 share dumps on the open market.  Shorty, shorty, short, short.

What does the 2022 AGM look like given just these two recent developments alone?  As asked by someone who has been questioning shareholder treatment for at least three years.
DF

<< Previous
Bullboard Posts
Next >>